Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Veru Inc (VERU)

Veru Inc (VERU)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 466,456
  • Shares Outstanding, K 80,147
  • Annual Sales, $ 61,260 K
  • Annual Income, $ 7,390 K
  • 60-Month Beta -0.33
  • Price/Sales 9.08
  • Price/Cash Flow N/A
  • Price/Book 3.77
Trade VERU with:

Options Overview Details

View History
  • Implied Volatility 228.42% ( +30.24%)
  • Historical Volatility 250.08%
  • IV Percentile 76%
  • IV Rank 58.01%
  • IV High 344.73% on 09/07/22
  • IV Low 67.74% on 04/08/22
  • Put/Call Vol Ratio 0.09
  • Today's Volume 1,478
  • Volume Avg (30-Day) 18,078
  • Put/Call OI Ratio 0.56
  • Today's Open Interest 162,327
  • Open Int (30-Day) 206,731

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.29
  • Number of Estimates 2
  • High Estimate -0.27
  • Low Estimate -0.31
  • Prior Year -0.08
  • Growth Rate Est. (year over year) -262.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.15 +21.94%
on 11/22/22
15.90 -60.50%
on 11/07/22
-4.07 (-39.32%)
since 11/04/22
3-Month
5.15 +21.94%
on 11/22/22
16.53 -62.01%
on 09/07/22
-8.31 (-56.96%)
since 09/06/22
52-Week
4.34 +44.70%
on 04/08/22
24.55 -74.42%
on 08/17/22
+0.10 (+1.62%)
since 12/06/21

Most Recent Stories

More News
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Veru Inc. - VERU

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Veru, Inc. ("Veru" or the "Company") (NASDAQ: VERU). Such investors are advised...

VERU : 6.20 (+6.53%)
Veru Inc. (VERU) Reports Q4 Loss, Lags Revenue Estimates

Veru Inc. (VERU) delivered earnings and revenue surprises of -75.86% and 77.51%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

VERU : 6.20 (+6.53%)
LFCR : 8.03 (+1.58%)
Is Veru a Buy?

Or is it just another risky COVID stock?

VERU : 6.20 (+6.53%)
ROSEN, A LEADING LAW FIRM, Encourages Veru Inc. Investors to Inquire About Securities Class Action Investigation - VERU

/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Veru...

VERU : 6.20 (+6.53%)
Is It Too Late to Buy Veru Stock?

The negative impact of its COVID-19 program faltering will soon be in the past.

VERU : 6.20 (+6.53%)
Meridian Bioscience (VIVO) Q4 Earnings Surpass Estimates

Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 33.33% and 2.63%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

VIVO : 31.89 (-0.34%)
VERU : 6.20 (+6.53%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Veru Inc. - VERU

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Veru, Inc. ("Veru" or the "Company") (NASDAQ: VERU). Such investors are advised...

VERU : 6.20 (+6.53%)
Why Shares of Veru Fell 10.33% on Monday

Investors are concerned that approval for a COVID-19 therapy will be delayed or denied.

VERU : 6.20 (+6.53%)
LLY : 368.94 (-0.09%)
VERU BREAKING NEWS: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Veru Inc. Investors to Inquire About Securities Class Action Investigation - VERU

/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of...

VERU : 6.20 (+6.53%)
VERU ALERT: Bragar Eagel & Squire, P.C. is Investigating Veru Inc. on Behalf of Veru Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Veru Inc. (“Veru” or the “Company”) (NASDAQ: VERU) on behalf of Veru...

VERU : 6.20 (+6.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Veru Inc. engages in the development, manufacture and marketing of consumer health care products. It focuses on producing FC2 female condom which provides dual protection against unintended pregnancy and sexually transmitted infections. Veru Inc., formerly known as The Female Health Company, is headquartered...

See More

Key Turning Points

3rd Resistance Point 7.59
2nd Resistance Point 7.06
1st Resistance Point 6.44
Last Price 6.20
1st Support Level 5.29
2nd Support Level 4.76
3rd Support Level 4.14

See More

52-Week High 24.55
Fibonacci 61.8% 16.83
Fibonacci 50% 14.44
Fibonacci 38.2% 12.06
Last Price 6.20
52-Week Low 4.34

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar